The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
α-blockers or α-adrenoreceptor antagonists, are a class of pharmacological agents that act as antagonists on α-adrenergic receptors (α-adrenoceptors).
The global α-blocker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for α-blocker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for α-blocker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of α-blocker include Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb and Bayer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for α-blocker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding α-blocker.
Report Scope
The α-blocker market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global α-blocker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the α-blocker manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Segment by Type
Non-selective Antagonists
Selective Antagonists
Segment by Application
Hypertension
Raynaud's Disease
Erectile Dysfunction
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of α-blocker manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of α-blocker in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
α-blockers or α-adrenoreceptor antagonists, are a class of pharmacological agents that act as antagonists on α-adrenergic receptors (α-adrenoceptors).
The global α-blocker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for α-blocker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for α-blocker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of α-blocker include Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb and Bayer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for α-blocker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding α-blocker.
Report Scope
The α-blocker market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global α-blocker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the α-blocker manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Segment by Type
Non-selective Antagonists
Selective Antagonists
Segment by Application
Hypertension
Raynaud's Disease
Erectile Dysfunction
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of α-blocker manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of α-blocker in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 α-blocker Market Overview
1.1 Product Overview and Scope of α-blocker
1.2 α-blocker Segment by Type
1.2.1 Global α-blocker Market Value Comparison by Type (2024-2030)
1.2.2 Non-selective Antagonists
1.2.3 Selective Antagonists
1.3 α-blocker Segment by Application
1.3.1 Global α-blocker Market Value by Application: (2024-2030)
1.3.2 Hypertension
1.3.3 Raynaud's Disease
1.3.4 Erectile Dysfunction
1.4 Global α-blocker Market Size Estimates and Forecasts
1.4.1 Global α-blocker Revenue 2019-2030
1.4.2 Global α-blocker Sales 2019-2030
1.4.3 Global α-blocker Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 α-blocker Market Competition by Manufacturers
2.1 Global α-blocker Sales Market Share by Manufacturers (2019-2024)
2.2 Global α-blocker Revenue Market Share by Manufacturers (2019-2024)
2.3 Global α-blocker Average Price by Manufacturers (2019-2024)
2.4 Global α-blocker Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of α-blocker, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of α-blocker, Product Type & Application
2.7 α-blocker Market Competitive Situation and Trends
2.7.1 α-blocker Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest α-blocker Players Market Share by Revenue
2.7.3 Global α-blocker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 α-blocker Retrospective Market Scenario by Region
3.1 Global α-blocker Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global α-blocker Global α-blocker Sales by Region: 2019-2030
3.2.1 Global α-blocker Sales by Region: 2019-2024
3.2.2 Global α-blocker Sales by Region: 2025-2030
3.3 Global α-blocker Global α-blocker Revenue by Region: 2019-2030
3.3.1 Global α-blocker Revenue by Region: 2019-2024
3.3.2 Global α-blocker Revenue by Region: 2025-2030
3.4 North America α-blocker Market Facts & Figures by Country
3.4.1 North America α-blocker Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America α-blocker Sales by Country (2019-2030)
3.4.3 North America α-blocker Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe α-blocker Market Facts & Figures by Country
3.5.1 Europe α-blocker Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe α-blocker Sales by Country (2019-2030)
3.5.3 Europe α-blocker Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific α-blocker Market Facts & Figures by Country
3.6.1 Asia Pacific α-blocker Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific α-blocker Sales by Country (2019-2030)
3.6.3 Asia Pacific α-blocker Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America α-blocker Market Facts & Figures by Country
3.7.1 Latin America α-blocker Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America α-blocker Sales by Country (2019-2030)
3.7.3 Latin America α-blocker Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa α-blocker Market Facts & Figures by Country
3.8.1 Middle East and Africa α-blocker Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa α-blocker Sales by Country (2019-2030)
3.8.3 Middle East and Africa α-blocker Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global α-blocker Sales by Type (2019-2030)
4.1.1 Global α-blocker Sales by Type (2019-2024)
4.1.2 Global α-blocker Sales by Type (2025-2030)
4.1.3 Global α-blocker Sales Market Share by Type (2019-2030)
4.2 Global α-blocker Revenue by Type (2019-2030)
4.2.1 Global α-blocker Revenue by Type (2019-2024)
4.2.2 Global α-blocker Revenue by Type (2025-2030)
4.2.3 Global α-blocker Revenue Market Share by Type (2019-2030)
4.3 Global α-blocker Price by Type (2019-2030)
5 Segment by Application
5.1 Global α-blocker Sales by Application (2019-2030)
5.1.1 Global α-blocker Sales by Application (2019-2024)
5.1.2 Global α-blocker Sales by Application (2025-2030)
5.1.3 Global α-blocker Sales Market Share by Application (2019-2030)
5.2 Global α-blocker Revenue by Application (2019-2030)
5.2.1 Global α-blocker Revenue by Application (2019-2024)
5.2.2 Global α-blocker Revenue by Application (2025-2030)
5.2.3 Global α-blocker Revenue Market Share by Application (2019-2030)
5.3 Global α-blocker Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer α-blocker Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer α-blocker Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis α-blocker Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis α-blocker Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck α-blocker Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck α-blocker Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Astra Zeneca
6.4.1 Astra Zeneca Corporation Information
6.4.2 Astra Zeneca Description and Business Overview
6.4.3 Astra Zeneca α-blocker Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Astra Zeneca α-blocker Product Portfolio
6.4.5 Astra Zeneca Recent Developments/Updates
6.5 Jhonson and Johnson
6.5.1 Jhonson and Johnson Corporation Information
6.5.2 Jhonson and Johnson Description and Business Overview
6.5.3 Jhonson and Johnson α-blocker Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Jhonson and Johnson α-blocker Product Portfolio
6.5.5 Jhonson and Johnson Recent Developments/Updates
6.6 Eli Lilly
6.6.1 Eli Lilly Corporation Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly α-blocker Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Eli Lilly α-blocker Product Portfolio
6.6.5 Eli Lilly Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi α-blocker Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi α-blocker Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Bristol-Myers Squibb
6.8.1 Bristol-Myers Squibb Corporation Information
6.8.2 Bristol-Myers Squibb Description and Business Overview
6.8.3 Bristol-Myers Squibb α-blocker Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bristol-Myers Squibb α-blocker Product Portfolio
6.8.5 Bristol-Myers Squibb Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Corporation Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer α-blocker Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bayer α-blocker Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 GSK
6.10.1 GSK Corporation Information
6.10.2 GSK Description and Business Overview
6.10.3 GSK α-blocker Sales, Revenue and Gross Margin (2019-2024)
6.10.4 GSK α-blocker Product Portfolio
6.10.5 GSK Recent Developments/Updates
6.11 Teva Pharmaceutical
6.11.1 Teva Pharmaceutical Corporation Information
6.11.2 Teva Pharmaceutical α-blocker Description and Business Overview
6.11.3 Teva Pharmaceutical α-blocker Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Teva Pharmaceutical α-blocker Product Portfolio
6.11.5 Teva Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 α-blocker Industry Chain Analysis
7.2 α-blocker Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 α-blocker Production Mode & Process
7.4 α-blocker Sales and Marketing
7.4.1 α-blocker Sales Channels
7.4.2 α-blocker Distributors
7.5 α-blocker Customers
8 α-blocker Market Dynamics
8.1 α-blocker Industry Trends
8.2 α-blocker Market Drivers
8.3 α-blocker Market Challenges
8.4 α-blocker Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global α-blocker Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global α-blocker Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global α-blocker Market Competitive Situation by Manufacturers in 2023
Table 4. Global α-blocker Sales (K MT) of Key Manufacturers (2019-2024)
Table 5. Global α-blocker Sales Market Share by Manufacturers (2019-2024)
Table 6. Global α-blocker Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global α-blocker Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market α-blocker Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of α-blocker, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of α-blocker, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of α-blocker, Product Type & Application
Table 12. Global Key Manufacturers of α-blocker, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global α-blocker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in α-blocker as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global α-blocker Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global α-blocker Sales by Region (2019-2024) & (K MT)
Table 18. Global α-blocker Sales Market Share by Region (2019-2024)
Table 19. Global α-blocker Sales by Region (2025-2030) & (K MT)
Table 20. Global α-blocker Sales Market Share by Region (2025-2030)
Table 21. Global α-blocker Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global α-blocker Revenue Market Share by Region (2019-2024)
Table 23. Global α-blocker Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global α-blocker Revenue Market Share by Region (2025-2030)
Table 25. North America α-blocker Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America α-blocker Sales by Country (2019-2024) & (K MT)
Table 27. North America α-blocker Sales by Country (2025-2030) & (K MT)
Table 28. North America α-blocker Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America α-blocker Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe α-blocker Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe α-blocker Sales by Country (2019-2024) & (K MT)
Table 32. Europe α-blocker Sales by Country (2025-2030) & (K MT)
Table 33. Europe α-blocker Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe α-blocker Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific α-blocker Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific α-blocker Sales by Region (2019-2024) & (K MT)
Table 37. Asia Pacific α-blocker Sales by Region (2025-2030) & (K MT)
Table 38. Asia Pacific α-blocker Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific α-blocker Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America α-blocker Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America α-blocker Sales by Country (2019-2024) & (K MT)
Table 42. Latin America α-blocker Sales by Country (2025-2030) & (K MT)
Table 43. Latin America α-blocker Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America α-blocker Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa α-blocker Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa α-blocker Sales by Country (2019-2024) & (K MT)
Table 47. Middle East & Africa α-blocker Sales by Country (2025-2030) & (K MT)
Table 48. Middle East & Africa α-blocker Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa α-blocker Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global α-blocker Sales (K MT) by Type (2019-2024)
Table 51. Global α-blocker Sales (K MT) by Type (2025-2030)
Table 52. Global α-blocker Sales Market Share by Type (2019-2024)
Table 53. Global α-blocker Sales Market Share by Type (2025-2030)
Table 54. Global α-blocker Revenue (US$ Million) by Type (2019-2024)
Table 55. Global α-blocker Revenue (US$ Million) by Type (2025-2030)
Table 56. Global α-blocker Revenue Market Share by Type (2019-2024)
Table 57. Global α-blocker Revenue Market Share by Type (2025-2030)
Table 58. Global α-blocker Price (USD/MT) by Type (2019-2024)
Table 59. Global α-blocker Price (USD/MT) by Type (2025-2030)
Table 60. Global α-blocker Sales (K MT) by Application (2019-2024)
Table 61. Global α-blocker Sales (K MT) by Application (2025-2030)
Table 62. Global α-blocker Sales Market Share by Application (2019-2024)
Table 63. Global α-blocker Sales Market Share by Application (2025-2030)
Table 64. Global α-blocker Revenue (US$ Million) by Application (2019-2024)
Table 65. Global α-blocker Revenue (US$ Million) by Application (2025-2030)
Table 66. Global α-blocker Revenue Market Share by Application (2019-2024)
Table 67. Global α-blocker Revenue Market Share by Application (2025-2030)
Table 68. Global α-blocker Price (USD/MT) by Application (2019-2024)
Table 69. Global α-blocker Price (USD/MT) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer α-blocker Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 73. Pfizer α-blocker Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis α-blocker Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 78. Novartis α-blocker Product
Table 79. Novartis Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck α-blocker Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 83. Merck α-blocker Product
Table 84. Merck Recent Developments/Updates
Table 85. Astra Zeneca Corporation Information
Table 86. Astra Zeneca Description and Business Overview
Table 87. Astra Zeneca α-blocker Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 88. Astra Zeneca α-blocker Product
Table 89. Astra Zeneca Recent Developments/Updates
Table 90. Jhonson and Johnson Corporation Information
Table 91. Jhonson and Johnson Description and Business Overview
Table 92. Jhonson and Johnson α-blocker Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 93. Jhonson and Johnson α-blocker Product
Table 94. Jhonson and Johnson Recent Developments/Updates
Table 95. Eli Lilly Corporation Information
Table 96. Eli Lilly Description and Business Overview
Table 97. Eli Lilly α-blocker Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 98. Eli Lilly α-blocker Product
Table 99. Eli Lilly Recent Developments/Updates
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi α-blocker Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 103. Sanofi α-blocker Product
Table 104. Sanofi Recent Developments/Updates
Table 105. Bristol-Myers Squibb Corporation Information
Table 106. Bristol-Myers Squibb Description and Business Overview
Table 107. Bristol-Myers Squibb α-blocker Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 108. Bristol-Myers Squibb α-blocker Product
Table 109. Bristol-Myers Squibb Recent Developments/Updates
Table 110. Bayer Corporation Information
Table 111. Bayer Description and Business Overview
Table 112. Bayer α-blocker Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 113. Bayer α-blocker Product
Table 114. Bayer Recent Developments/Updates
Table 115. GSK Corporation Information
Table 116. GSK Description and Business Overview
Table 117. GSK α-blocker Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 118. GSK α-blocker Product
Table 119. GSK Recent Developments/Updates
Table 120. Teva Pharmaceutical Corporation Information
Table 121. Teva Pharmaceutical Description and Business Overview
Table 122. Teva Pharmaceutical α-blocker Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 123. Teva Pharmaceutical α-blocker Product
Table 124. Teva Pharmaceutical Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. α-blocker Distributors List
Table 128. α-blocker Customers List
Table 129. α-blocker Market Trends
Table 130. α-blocker Market Drivers
Table 131. α-blocker Market Challenges
Table 132. α-blocker Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of α-blocker
Figure 2. Global α-blocker Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global α-blocker Market Share by Type in 2023 & 2030
Figure 4. Non-selective Antagonists Product Picture
Figure 5. Selective Antagonists Product Picture
Figure 6. Global α-blocker Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global α-blocker Market Share by Application in 2023 & 2030
Figure 8. Hypertension
Figure 9. Raynaud's Disease
Figure 10. Erectile Dysfunction
Figure 11. Global α-blocker Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global α-blocker Market Size (2019-2030) & (US$ Million)
Figure 13. Global α-blocker Sales (2019-2030) & (K MT)
Figure 14. Global α-blocker Average Price (USD/MT) & (2019-2030)
Figure 15. α-blocker Report Years Considered
Figure 16. α-blocker Sales Share by Manufacturers in 2023
Figure 17. Global α-blocker Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest α-blocker Players: Market Share by Revenue in 2023
Figure 19. α-blocker Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global α-blocker Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America α-blocker Sales Market Share by Country (2019-2030)
Figure 22. North America α-blocker Revenue Market Share by Country (2019-2030)
Figure 23. U.S. α-blocker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada α-blocker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe α-blocker Sales Market Share by Country (2019-2030)
Figure 26. Europe α-blocker Revenue Market Share by Country (2019-2030)
Figure 27. Germany α-blocker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France α-blocker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. α-blocker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy α-blocker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia α-blocker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific α-blocker Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific α-blocker Revenue Market Share by Region (2019-2030)
Figure 34. China α-blocker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan α-blocker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea α-blocker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India α-blocker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia α-blocker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan α-blocker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia α-blocker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand α-blocker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia α-blocker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines α-blocker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America α-blocker Sales Market Share by Country (2019-2030)
Figure 45. Latin America α-blocker Revenue Market Share by Country (2019-2030)
Figure 46. Mexico α-blocker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil α-blocker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina α-blocker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa α-blocker Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa α-blocker Revenue Market Share by Country (2019-2030)
Figure 51. Turkey α-blocker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia α-blocker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E α-blocker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of α-blocker by Type (2019-2030)
Figure 55. Global Revenue Market Share of α-blocker by Type (2019-2030)
Figure 56. Global α-blocker Price (USD/MT) by Type (2019-2030)
Figure 57. Global Sales Market Share of α-blocker by Application (2019-2030)
Figure 58. Global Revenue Market Share of α-blocker by Application (2019-2030)
Figure 59. Global α-blocker Price (USD/MT) by Application (2019-2030)
Figure 60. α-blocker Value Chain
Figure 61. α-blocker Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
